Matches in Wikidata for { <http://www.wikidata.org/entity/Q65542978> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q65542978 description "clinical trial" @default.
- Q65542978 description "ensayu clínicu" @default.
- Q65542978 description "klinisch onderzoek" @default.
- Q65542978 description "клінічне випробування" @default.
- Q65542978 name "Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines" @default.
- Q65542978 name "Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines" @default.
- Q65542978 type Item @default.
- Q65542978 label "Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines" @default.
- Q65542978 label "Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines" @default.
- Q65542978 prefLabel "Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines" @default.
- Q65542978 prefLabel "Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines" @default.
- Q65542978 P1050 Q65542978-6E342E8B-AD34-4EE6-8D1A-D1371C1FE1F3 @default.
- Q65542978 P1132 Q65542978-30CC361A-0F1A-4715-AC0C-967391EE6A40 @default.
- Q65542978 P1476 Q65542978-1E104590-03DD-4788-B253-E8E6E9BBA166 @default.
- Q65542978 P17 Q65542978-3F9D6547-1B35-45CC-8691-F8C7832B7C13 @default.
- Q65542978 P2899 Q65542978-59BBF84D-ED2D-4800-98A7-A9F4FA2F1CD7 @default.
- Q65542978 P3098 Q65542978-13CADD0C-5E13-47B2-9477-2CFCD826ECC3 @default.
- Q65542978 P31 Q65542978-9684B8F6-54C5-40C7-B5E0-D43C1F8FA001 @default.
- Q65542978 P580 Q65542978-67019977-7D69-495B-9C8E-EFAD6F1A2318 @default.
- Q65542978 P6099 Q65542978-BE30E3E2-084D-484C-82CD-D412CD1A2383 @default.
- Q65542978 P8363 Q65542978-4F03E776-CD4C-4AF9-A476-EAF4DCA8D468 @default.
- Q65542978 P1050 Q181754 @default.
- Q65542978 P1132 "+160" @default.
- Q65542978 P1476 "A Double-blind, Randomised, Placebo-controlled, Parallel-group, Multicentre, Phase III Study to Assess the Impact of Rosuvastatin Treatment for 26 Weeks (Titrated to a Maximum Dose of 40mg Once Daily) on Left Ventricular Function, Cytokines and Lipid Parameters in Patients With Established Systolic Chronic Heart Failure." @default.
- Q65542978 P17 Q408 @default.
- Q65542978 P2899 "+18" @default.
- Q65542978 P3098 "NCT00240292" @default.
- Q65542978 P31 Q30612 @default.
- Q65542978 P580 "2003-02-01T00:00:00Z" @default.
- Q65542978 P6099 Q42824827 @default.
- Q65542978 P8363 Q78089383 @default.